Short answer. The notice names three compounders: a state-licensed pharmacy, a federal facility, or a licensed physician [1]. A website that ships vials labeled "research use only" or "not for human consumption" is none of those. As of Oct 29, 2026.

HHS states the contrast on purpose

The policy says this limited discretion is meant to discourage continued, widespread use of certain research-use-only peptides supplied by foreign manufacturers that pose a safety risk to U.S. patients, and to describe a more controlled alternative under safeguards [2].

Read that as a warning about the gray market, not as a coupon for it. The announcement does not bless the vial that was already in the mail. It describes a different channel, with a prescription, a registered manufacturer, a certificate of analysis, one active ingredient, a compounded-drug label, and the other conditions [2].

How to tell the two apart

FDA has not treated a research-use label as the end of the question when a site markets the product for people. That point is already on Prescription vs research peptides.

Sommar Club does not prescribe or sell these six. If a clinician is considering a compounded medicine that does have a legal path, that conversation is with the clinician, not with a checkout page.

FAQ

The shop added "now legal under HHS" to the same vial. Does the policy cover it? Only if the seller is a covered compounder and every condition is met [1][2]. A new banner does not change who compounded it.

Is the gray market safer because the policy exists? The policy says the opposite about research-use-only supply from foreign manufacturers [2].

Sources

1. HHS notice, FR Doc. 2026-22192, filed Oct 28, 2026. https://public-inspection.federalregister.gov/2026-22192.pdf

2. HHS policy, purpose statement and conditions. https://www.hhs.gov/sites/default/files/hhs-503a-peptide-enforcement-discretion-policy-appendix-b.pdf

Education only. Not medical or legal advice. As of Oct 29, 2026.